1 |
JIA X C, XIA Z H, SHI N, et al. The factors associated with natural disease progression from HIV to AIDS in the absence of ART, a propensity score matching analysis[J]. Epidemiology and Infection, 2020, 148: e57.
|
2 |
KAZER S W, WALKER B D, SHALEK A K. Evolution and diversity of immune responses during acute HIV Infection[J]. Immunity, 2020, 53(5): 908-924.
|
3 |
LI Y Y, YANG S H, WANG R R, et al. Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV/AIDS patients in Yunnan, China[J]. International Journal of Dermatology, 2020, 59(3): 308-313.
|
4 |
黄山, 吕松琴, 段洪芬, 等. 机会性感染病原体对新发艾滋病患者抗病毒治疗过程中T淋巴细胞亚群分布影响的队列研究[J]. 昆明医科大学学报, 2021, 42(11): 159-165.
|
5 |
毛佳妮. 基于多水平发展模型的艾滋病患者CD4+T淋巴细胞计数变化趋势及其影响因素研究[D]. 重庆: 重庆医科大学, 2022.
|
6 |
COHN L B, CHOMONT N, DEEKS S G. The biology of the HIV-1 latent reservoir and implications for cure Strategies[J]. Cell Host and Microbe, 2020, 27(4): 519-530.
|
7 |
中华人民共和国国家统计局. 中国统计年鉴[M]. 北京: 中国统计出版社, 2019: 23-24.
|
8 |
ASH M K, AL-HARTHI L, SCHNEIDER J R. HIV in the brain: identifying viral reservoirs and addressing the challenges of an HIV cure[J]. Vaccines, 2021, 9(8): 867.
|
9 |
GALLO R C. HIV/AIDS research for the future[J]. Cell Host and Microbe, 2020, 27(4): 499-501.
|
10 |
陈格格, 邓婷婷, 李少伟, 等. HIV-1 Env免疫原设计的研究进展[J]. 中国艾滋病性病, 2022, 28(5): 603-607.
|
11 |
XIAO T S, CAI Y, CHEN B. HIV-1 entry and membrane fusion inhibitors[J]. Viruses, 2021, 13(5): 735.
|
12 |
CHEN J, LI CY, LI R, et al. Exosomes in HIV infection[J]. Current Opinion in HIV and AIDS, 2021, 16(5): 262-270.
|
13 |
AIKEN C, ROUSSO I. The HIV-1 capsid and reverse transcription[J]. Retrovirology, 2021, 18(1): 29.
|
14 |
SALAMANGO D J, HARRIS R S. Demystifying cell cycle arrest by HIV-1 Vif[J]. Trends in Microbiology, 2021, 29(5): 381-384.
|
15 |
YANG X D, SU B, ZHANG X, et al. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: challenges of immunological non-responders[J]. Journal of Leukocyte Biology, 2020, 107(4): 597-612.
|
16 |
VANSANT G, BRUGGEMANS A, JANSSENS J, et al. Block-and-lock strategies to cure HIV Infection[J]. Viruses, 2020, 12(1): 84.
|
17 |
CRIBBS S K, CROTHERS K, MORRIS A. Pathogenesis of HIV-related lung disease: immunity, infection, and inflammation[J]. Physiological Reviews, 2020, 100(2): 603-632.
|
18 |
DE COCK K M, JAFFE H W, CURRAN J W. Reflections on 40 years of AIDS[J]. Emerging Infectious Diseases, 2021, 27(6): 1553-1560.
|
19 |
GHOSN J, TAIWO B, SEEDAT S, et al. HIV[J]. Lancet, 2018, 392(10148): 685-697.
|
20 |
GULICK R M, FLEXNER C. Long-acting HIV drugs for treatment and prevention[J]. Annual Review of Medicine, 2019, 70: 137-150.
|
21 |
CHEN B. Molecular mechanism of HIV-1 entry[J]. Trends in Microbiology, 2019, 27(10): 878-891.
|
22 |
金聪, 邱茂锋, 潘品良, 等. 中国艾滋病抗病毒治疗20年的实验室检测进展与成就[J]. 中国艾滋病性病, 2022, 28(5): 505-508.
|
23 |
杨红红, 孟慧玲, 李明丹, 等. 艾滋病肺孢子菌肺炎患者合并巨细胞病毒共感染的危险因素分析[J]. 中国感染与化疗杂志, 2022, 22(6): 670-674.
|
24 |
黄山, 吕松琴, 徐丽萍, 等. 2015-2019年云南地区HIV感染者/AIDS患者合并感染病原微生物特征分析[J]. 临床检验杂志, 2021, 39(2): 151-153
|
25 |
中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版)[J]. 中华传染病杂志, 2021, 39(12): 715-735.
|